Colleges
Websites
-
MRC Molecular Haematology Unit
Research Unit
-
MRC Weatherall Institute of Molecular Medicine
Research Institute
DPhil projects available
Molecular dissection of blood cell fate determination
POst-doctoral position available
Position in Structural and Stem Cell Biology
https://www.recruit.ox.ac.uk/pls/hrisliverecruit/erq_jobspec_version_4.jobspec?p_id=139214
Catherine Porcher
PhD, MSc, BSc (Hons)
Associate Professor of Developmental and Stem Cell Biology
Molecular dissection of blood cell fate determination
My research interests lie in cell fate mechanisms and, in particular, in the specification of blood stem cells during development. I received my PhD from University of Paris VII, where I studied red blood cell differentiation through the regulation of genes involved in the haem biosynthetic pathway. I then joined the lab of Stuart Orkin at Harvard University for my post-doctoral training. There, I developed a broader interest in haematopoiesis and unveiled the essential function of the regulator SCL/TAL1 in the development of all blood lineages, placing it at the apex of the haematopoietic transcriptional hierarchy. In 1999, I joined the MRC Molecular Haematology Unit as a principal investigator.
Currently, my group studies the developmental trajectory of the blood stem cell lineage from its specification in mesoderm through to production of blood cells using in vivo lineage tracing and single cell genomics/transcriptomics/imaging approaches. We also study the transcriptional and epigenetic regulation of the earliest events controlling blood specification through integration of molecular, biochemical, genetics and structural approaches. This work will lead to a better understanding of the fundamental biological processes underlying cell fate determination that, when corrupted, can lead to pathologies such as cancer. Our work will also contribute to the development of protocols supporting the generation of blood stem cells in vitro, thereby offering novel opportunities to treat inherited blood diseases.
As a woman and mother of two, I am keen to support the career of young female scientists and chair the WIMM Diversity and Inclusion committee. I am also enrolled in the RDM mentoring scheme.
Key publications
-
SCL/TAL1 cooperates with Polycomb RYBP-PRC1 to suppress alternative lineages in blood-fated cells.
Journal article
Chagraoui H. et al, (2018), Nat Commun, 9
-
SCL/TAL1: a multifaceted regulator from blood development to disease.
Journal article
Porcher C. et al, (2017), Blood, 129, 2051 - 2060
-
EphrinB2 regulates the emergence of a hemogenic endothelium from the aorta.
Journal article
Chen I-I. et al, (2016), Sci Rep, 6
-
Uncoupling VEGFA functions in arteriogenesis and hematopoietic stem cell specification.
Journal article
Leung A. et al, (2013), Dev Cell, 24, 144 - 158
Recent publications
-
Specification of the haematopoietic stem cell lineage: From blood-fated mesodermal angioblasts to haemogenic endothelium.
Journal article
Ho VW. et al, (2022), Semin Cell Dev Biol
-
Publisher Correction: The T-box transcription factor Eomesodermin governs haemogenic competence of yolk sac mesodermal progenitors.
Journal article
Harland LTG. et al, (2021), Nat Cell Biol
-
The T-box transcription factor Eomesodermin governs haemogenic competence of yolk sac mesodermal progenitors.
Journal article
Harland LTG. et al, (2021), Nat Cell Biol, 23, 61 - 74
-
EOMESODERMIN GOVERNS THE HEMOGENIC COMPETENCE OF MURINE YOLK-SAC MESODERMAL PROGENITORS
Conference paper
Harland L. et al, (2020), EXPERIMENTAL HEMATOLOGY, 88, S34 - S34
-
Oncogenic Gata1 causes stage-specific megakaryocyte differentiation delay.
Journal article
Juban G. et al, (2020), Haematologica
ORCID
0000-0002-9015-5203
